Eurofins Scientific (-4.75% €89.80)
Eurofins Scientific finished last in the CAC 40 in the crowd for the publication of its quarterly business update. The analysis laboratory has nevertheless achieved a turnover better than expected and raised its annual objectives, but the consensus is more ambitious for 2022. Analysts expect a turnover of 6.411 billion and an EBITDA of 1.546 billion euros. euros over the financial year, while Eurofins is targeting 6.325 billion euros and 1.525 billion respectively.
Eurofins Scientific finished last in the CAC 40 in the crowd for the publication of its quarterly business update. The analysis laboratory has nevertheless achieved a turnover better than expected and raised its annual objectives, but the consensus is more ambitious for 2022. Analysts expect a turnover of 6.411 billion and an EBITDA of 1.546 billion euros. euros over the financial year, while Eurofins is targeting 6.325 billion euros and 1.525 billion respectively.